Étude de cas
Experiences with the MCV 5-dose Switch from Africa’s EPI
This video series features EPI managers, along with UNICEF and WHO regional leads, sharing firsthand experiences from countries that have transitioned from 10-dose to 5-dose measles-containing vaccine (MCV) vials for routine immunization. Speakers discuss why countries have pursued the switch, how transitions were planned and implemented, and observed impacts on vaccination coverage, session frequency, wastage, and program efficiency.
The interviews were recorded by UNICEF ESARO during the 2023 EPI Managers’ Meeting in Addis Ababa, with additional follow-up discussions conducted at the UNICEF Regional Office in Kenya. This resource is useful for early-phase orientation and peer learning, helping country teams understand the rationale for the switch and anticipate implementation considerations.
Auteurs
Langues
- Anglais
Année de publication
2024
Type
Étude de cas
Catégories
- Vaccins et dispositifs d'administration
Maladies
- Rougeole
- Rubéole
Mots-clés
- Présentation et emballage des vaccins
Régions de l'OMS
- Région africaine
MCV5 PHASE 1
Vous pouvez trouver plus d’informations sur "MCV5 PHASE 1" dans les rubriques suivantes :
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| Measles and Measles-Rubella (MR) Vaccine Five-Dose Vial Presentation - Fact Sheet 2022 - 2023 | UNICEF, World Health Organization (WHO) | 2022 | Guidance | Anglais |
| MCV 5-dose Research and Resources | Linksbridge | 2022 | Report | Anglais |
| MCV 5-dose National Impact Assessment Tool | Linksbridge | 2026 | Tool | Anglais, Français |
| Experiences with the MCV 5-dose Switch from Africa’s EPI | UNICEF | 2024 | Case study | Anglais |
| How To Use: Step-by-Step Instructions for the MCV 5-dose National Impact Assessment Tool | Linksbridge | 2025 | User guide | Anglais |
| MCV 5-dose Option Overview | Linksbridge | 2026 | Guidance | Anglais |
| MCV 5-dose 2-Pager | Linksbridge | 2026 | Guidance | Anglais |
